In Vitro Activity of a Novel Diaminopyrimidine Compound, Iclaprim, against Chlamydia trachomatis and C. pneumoniae

The in vitro activities of iclaprim, a novel dihydrofolate reductase inhibitor, azithromycin, and levofloxacin were tested against 10 strains of Chlamydia trachomatis and 10 isolates of Chlamydia pneumoniae. For C. trachomatis and C. pneumoniae, the iclaprim MIC and minimal bactericidal concentratio...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Kohlhoff, S. A., Roblin, P. M., Reznik, T., Hawser, S., Islam, K., Hammerschlag, M. R.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2004
Teme:
Susceptibility
Online dostop:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400585/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15105151/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.5.1885-1886.2004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki